Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022
Sign Up to like & getrecommendations! Published in 2023 at "Eurosurveillance"
DOI: 10.2807/1560-7917.es.2023.28.7.2300072
Abstract: While mpox was well characterised during the 2022 global Clade IIb outbreak, little is known about persistent morbidity. We present interim results of a prospective cohort study of 95 mpox patients assessed 3–20 weeks post-symptom… read more here.
Keywords: persistent morbidity; clade iib; interim results; mpox patients ... See more keywords